| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.03▼ | 6.08▼ | 6.05▼ | 6.02▲ | 6.25▼ |
| MA10 | 6.08▼ | 6.04▼ | 6.01▲ | 5.98▲ | 6.17▼ |
| MA20 | 6.09▼ | 6.03▲ | 6.03▲ | 6.16▼ | 6.60▼ |
| MA50 | 6.04▼ | 6.05▼ | 6.01▲ | 6.15▼ | 7.26▼ |
| MA100 | 6.05▼ | 5.98▲ | 6.21▼ | 6.65▼ | 7.26▼ |
| MA200 | 6.08▼ | 6.20▼ | 6.16▼ | 7.61▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.016▼ | 0.010▲ | 0.005▲ | -0.024▼ | -0.009▼ |
| RSI | 43.143▼ | 48.996▼ | 49.799▼ | 47.283▼ | 41.651▼ |
| STOCH | 3.125▼ | 72.473 | 56.167 | 39.767 | 45.578 |
| WILL %R | -86.364▼ | -55.882 | -55.882 | -67.586 | -67.586 |
| CCI | -96.267 | 22.781 | 11.754 | -38.368 | -63.409 |
|
Saturday, November 08, 2025 04:00 AM
Whilst it may not be a huge deal, we thought it was good to see that the Nuvectis Pharma, Inc. (NASDAQ:NVCT) Director, Juan Sanchez, recently bought US$75k worth of stock, for US$5.79 per share. While ...
|
|
Tuesday, November 04, 2025 02:30 AM
NXP900 Phase 1b program initiated; single agent study underway, aiming to provide preliminary evidence of clinical efficacy in patients with molecularly and histologically defined advanced cancers; in ...
|
|
Monday, October 27, 2025 08:39 AM
Nuvectis Pharma (NVCT) provided highlights for NXP900 poster presentations that took place last week at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 5.86 | 6.22 | 5.86 | 6.02 | 50,500 |
| 13/11/25 | 6.00 | 6.16 | 5.88 | 5.92 | 64,586 |
| 12/11/25 | 6.05 | 6.2675 | 5.99 | 6.01 | 46,357 |
| 11/11/25 | 6.08 | 6.13 | 5.98 | 6.06 | 56,868 |
| 10/11/25 | 6.27 | 6.40 | 6.01 | 6.07 | 85,300 |
| 07/11/25 | 5.68 | 6.215 | 5.55 | 6.14 | 148,500 |
| 06/11/25 | 5.88 | 6.04 | 5.64 | 5.67 | 132,476 |
| 05/11/25 | 5.85 | 5.90 | 5.65 | 5.65 | 128,157 |
| 04/11/25 | 6.21 | 6.21 | 5.80 | 5.88 | 143,068 |
| 03/11/25 | 6.71 | 6.71 | 6.23 | 6.36 | 76,800 |
|
|
||||
|
|
||||
|
|